Latest Peptides Stories

2009-09-03 07:30:00

BASKING RIDGE, N.J., Sept. 3 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the 11th Annual Healthcare Conference of the Rodman & Renshaw Global Investment Conference in New York, NY at 4:30 PM on Thursday, September 10, 2009 (EDT). Dr. Mazzo's presentation will include an overview of the...

2009-08-31 07:30:00

BASKING RIDGE, N.J., Aug. 31 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the results of a Phase 2a clinical trial of their lead product, the anticoagulant system REG1, were released at the European Society of Cardiology Congress in Barcelona, Spain. The results, detailed in a poster entitled, "First Clinical Application of an Actively Reversible Direct Acting Factor IXa...

2009-08-06 11:04:38

For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and "“ ideally "“ its effects will be reversible, to cut short any potentially dangerous side effects.University of Illinois researchers report that they have assembled a new cancer drug delivery system that, in cell culture, achieves all of the above. The findings appear this month in the journal Angewandte Chemie.The team began with the...

2009-08-05 14:04:55

A novel class of drugs composed of single strands of DNA or RNA, called aptamers, can bind protein targets with a high strength and specificity and are currently in clinical development as treatments for a broad range of common diseases, as described in a comprehensive review article published online ahead of print in Oligonucleotides, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article is available free online at www.liebertpub.com/oliAptamers offer...

2009-07-15 09:30:00

Researchers are reporting evidence from tissue culture experiments that the popular dietary supplement carnosine may help to prevent and treat cataracts, a clouding of the lens of the eye that is a leading cause of vision loss worldwide. The study is scheduled for the July 28 edition of ACS' Biochemistry, a weekly journal.In the new study, Enrico Rizzarelli and colleagues note that the only effective treatment for cataracts is surgical replacement of the lens, the clear disc-like structure...

2009-07-13 13:20:00

Researchers have invented computational tools to decode and rapidly determine whether natural compounds collected in oceans and forests are new"”or if these pharmaceutically promising compounds have already been described and are therefore not patentable.This University of California, San Diego advance will finally enable scientists to rapidly characterize ring-shaped nonribosomal peptides (NRPs)"”a class of natural compounds of intense interest due to their potential to yield or...

2009-04-07 13:10:59

New book provides an overview of aptamer development and applications Research and industry are increasingly exploiting the potential of aptamers. As well as their application in research, medical diagnosis and treatment, aptamers are also interesting as a basis for biosensors for use in environmental analysis because their characteristics enable them to identify and bind target molecules as surely as a key fits a lock. In a new book, researchers at the Helmholtz Centre for Environmental...

2009-03-30 10:20:00

Early Use of INTEGRILIN(R) Investigational Dosing is Not Superior to Delayed Provisional Use in Patients with High-Risk Acute Coronary Syndrome, Study Finds KENILWORTH, N.J., March 30 /PRNewswire-FirstCall/ -- In a study presented today at the 58th annual Scientific Sessions of the American College of Cardiology and simultaneously published by The New England Journal of Medicine, researchers reported that a strategy using an upstream, investigational dose of INTEGRILIN(R) (eptifibatide)...

2009-03-30 10:09:00

BASKING RIDGE, N.J., March 30 /PRNewswire/ -- Regado Biosciences today announced that the Company's Chief Executive Officer, David J. Mazzo, Ph.D., will be presenting at the upcoming 16th Annual Future Leaders in the Biotech Industry Conference to be held at the Millennium Broadway Hotel and Conference Center in New York City. Dr. Mazzo's presentation is scheduled to begin on Thursday, April 2, 2009 at 3:00 PM (EDT). A copy of Dr. Mazzo's presentation will also be available on the Company's...

2009-03-26 11:41:33

U.S. scientists say they've identified the genetic machinery responsible for synthesizing thiostrepton, a powerful antibiotic produced by certain bacteria. Georgia Institute of Technology Assistant Professor Wendy Kelly, postdoctoral fellow Chaoxuan Li and graduate student Lisa Pan said the antibiotic, although effective against the methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, thiostrepton has only limited applications in humans because it is not water...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'